Oxford Investment Consultants advises Thompson Taraz, the investment manager of Oxford Technology and Innovations Fund.
Business Model: B2B Consulting
Revenue: $0
Employees: 0-0
Address: 6 Grosvenor Street
City: Greater London
State: england
Zip: W1K 4PZ
Country: GB
xford Investment Consultants LLP ("OIC") advises Thompson Taraz, the Investment Manager of Oxford Technology and Innovations EIS Fund ("OTIF"). OIC is an Appointed Representative of Stoneware Captial LLP, which is authorized and regulated by the Financial Conduct Authority in the United Kingdom. The focus of OIC research is on University of Oxford spin out companies. Over the last fifteen years Oxford has produced a string of world-class spin-out companies. It is our belief that the next generation of world-class Oxford businesses is just waiting to be discovered.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2022 | Oxford Quantum Circuits | Series A | 45.4M |
6/2019 | Sphere Fluidics | Venture Round | 0 |
7/2019 | Zegami | Series B | 1.6M |
6/2019 | OrthoSon | Seed Round | 2.3M |
3/2021 | Caristo Diagnostics | Venture Round | - |
10/2018 | Caristo Diagnostics | Seed Round | 2.6M |
12/2021 | Navenio | Venture Round | 0 |
7/2019 | Zegami | Series B | 1.6M |
4/2023 | Caristo Diagnostics | Series A | 0 |
11/2022 | Diffblue | Series A | 0 |
6/2020 | Oxford Flow | Venture Round | 0 |
6/2017 | Diffblue | Series A | 21.8M |
8/2008 | Agilent Raman Spectroscopy | Seed Round | 1.4M |
5/2022 | Salience Labs | Seed Round | 11.5M |
7/2022 | Brill Power | Series A | 0 |
10/2017 | Oxford Biotrans | Series B | 2.8M |
2/2022 | Orthox Ltd. | Series A | 0 |
4/2021 | Oxford Endovascular | Series A | 0 |
2/2021 | SpyBiotech | Series A | 32.5M |
12/2017 | Navenio | Funding Round | 7.7M |
5/2020 | Navenio | Series A | 0 |
7/2022 | Brill Power | Series A | 0 |
7/2022 | Oxford Quantum Circuits | Series A | 0 |
5/2022 | Salience Labs | Seed Round | 0 |
2/2022 | Orthox Ltd. | Series A | 0 |
12/2021 | Navenio | Venture Round | 0 |
4/2021 | Oxford Endovascular | Series A | 0 |
3/2021 | Caristo Diagnostics | Venture Round | - |
2/2021 | SpyBiotech | Series A | 0 |
6/2020 | Oxford Flow | Venture Round | 0 |
5/2020 | Navenio | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|